Dose Escalation of IPI-493 in Hematologic Malignancies
Clinical trial NCT01193491 · TERMINATED
Trial details
- NCT number
- NCT01193491
- Sponsor
- Infinity Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-01
- Primary completion
- 2011-07-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.